118. How to Treat Resistant Gram-Positive Infections
Friday, October 5, 2018: 10:30 AM-11:45 AM
Room: N 24

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify the most current approaches for the treatment of severe infections caused by multidrug-resistant S. aureus
  • review the mechanisms of resistance and therapeutic options for vancomycin-resistant enterococci
  • discuss the impact of resistance in the treatment of pneumococcal infections.

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Researchers, Scientists

Tracks: Pediatric ID, Trainee, Global ID, Investigative ID, Adult ID

Moderators:  Cesar Arias, MD, PhD, FIDSA, University of Texas Health Science Center at Houston , David R. Andes, M.D., FIDSA, University of Wisconsin and Robert Bonomo, MD, Louis Stokes Cleveland VA Medical Center

10:30 AM
10:55 AM
Therapeutic Approaches for VRE
Truc T. Tran, PharmD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-230-L01-P


C. Arias, Merck & Co., Inc.: Grant Investigator , Research support . MeMed: Grant Investigator , Research support . Allergan: Grant Investigator , Research support .

D. R. Andes, None

R. Bonomo, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.